IRIS
GEBBIA, VITTORIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.764
EU - Europa 1.542
NA - Nord America 1.228
SA - Sud America 228
AF - Africa 10
Totale 4.772
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.206
IE - Irlanda 1.057
SG - Singapore 835
HK - Hong Kong 800
BR - Brasile 212
IT - Italia 113
DE - Germania 111
GB - Regno Unito 95
CN - Cina 59
CH - Svizzera 37
FI - Finlandia 37
NL - Olanda 20
CZ - Repubblica Ceca 14
RU - Federazione Russa 12
FR - Francia 10
AT - Austria 9
MX - Messico 9
CA - Canada 8
IN - India 7
IQ - Iraq 7
SE - Svezia 7
KR - Corea 6
MA - Marocco 6
UZ - Uzbekistan 6
AR - Argentina 5
BD - Bangladesh 5
AZ - Azerbaigian 4
EC - Ecuador 4
JP - Giappone 4
BE - Belgio 3
KZ - Kazakistan 3
LB - Libano 3
NP - Nepal 3
PK - Pakistan 3
PY - Paraguay 3
TR - Turchia 3
UA - Ucraina 3
VN - Vietnam 3
AL - Albania 2
IL - Israele 2
LT - Lituania 2
LV - Lettonia 2
PH - Filippine 2
RO - Romania 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
GR - Grecia 1
HN - Honduras 1
ID - Indonesia 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
PL - Polonia 1
PS - Palestinian Territory 1
PT - Portogallo 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TM - Turkmenistan 1
VE - Venezuela 1
Totale 4.772
Salva come PNG Salva come JPEG
Città #
Dublin 1.051
Hong Kong 797
Boardman 375
Santa Clara 307
Singapore 225
Ashburn 98
London 91
Zurich 37
Helsinki 36
Assago 32
Munich 28
Prineville 26
Fort Worth 24
Milan 24
Chandler 23
Chicago 20
Springfield 17
Los Angeles 15
São Paulo 15
Amsterdam 13
The Dalles 12
Washington 12
Berlin 9
Brno 9
Belo Horizonte 8
Naples 8
Ottawa 8
Shanghai 8
Nuremberg 7
Rio de Janeiro 6
Tashkent 6
Catania 5
Olomouc 5
Princeton 5
Seattle 5
Seoul 5
Vienna 5
Baku 4
Frankfurt am Main 4
Goiânia 4
Guangzhou 4
Modena 4
Tokyo 4
Baghdad 3
Belém 3
Brussels 3
Campinas 3
Cedar Knolls 3
Curitiba 3
Guayaquil 3
Ho Chi Minh City 3
Mexico City 3
Palermo 3
Philadelphia 3
Piscataway 3
Porto Alegre 3
Rome 3
Shenyang 3
Sorocaba 3
São José 3
Varallo Pombia 3
Arapiraca 2
Beijing 2
Betim 2
Boston 2
Bragança Paulista 2
Brasília 2
Buffalo 2
Cambridge 2
Campo Grande 2
Canela 2
Caraguatatuba 2
Cerquilho 2
Clifton 2
Guarulhos 2
Gurugram 2
Itaquaquecetuba 2
João Monlevade 2
Juiz de Fora 2
Kathmandu 2
Manaus 2
Mirassol 2
Moscow 2
Mosul 2
Natal 2
North Bergen 2
Oakland 2
Palhoça 2
Patos de Minas 2
Perm 2
Petrópolis 2
Piracicaba 2
Presidente Prudente 2
Riga 2
Shenzhen 2
São Bernardo do Campo 2
São João de Meriti 2
Tirana 2
Tremestieri Etneo 2
Trepuzzi 2
Totale 3.533
Salva come PNG Salva come JPEG
Nome #
112. UN NUOVO INDICE PROGNOSTICO-TERAPEUTICO IN ONCOLOGIA GERIATRICA 240
Is G8 geriatric assessment tool useful in managing elderly patients with metastatic pancreatic carcinoma? 67
Metronomic oral vinorelbine in patients with advanced non-small cell lung cancer progressing after nivolumab immunotherapy: a retrospective analysis 60
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies 60
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 55
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study 54
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study 52
Radium-223 treatment in castration resistant bone metastatic prostate cancer. Should be the primary tumor always treated? 52
Virtual Multidisciplinary Tumor Boards: A Narrative Review Focused on Lung Cancer 51
Harmful Interference of Detoxifying Diets and Nutraceuticals with Adherence to Abemaciclib in Advanced Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Breast Cancer: A Case Report 51
Patients With Cancer and COVID-19: A WhatsApp Messenger-Based Survey of Patients' Queries, Needs, Fears, and Actions Taken 50
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial 49
Reactions and countermeasures of medical oncologists towards the incoming COVID-19 pandemic: A whatsapp messenger-based report from the Italian college of chief medical oncologists 48
Oral vinorelbine and capecitabine as first-line therapy in metastatic breast cancer: a retrospective analysis 45
Gastric metastasis from breast cancer 43
A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy 42
A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer 41
Biomarker analysis of the phase 3 TORCH trial for first line erlotinib versus chemotherapy in advanced non-small cell lung cancer patients 39
null 37
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: Final results of the phase III randomized Short-HER study 36
Eribulin Mesylate for the Treatment of Metastatic Hormone-refractory and Triple-negative Breast Cancer: A Multi-institutional Real-world Report on Efficacy and Safety 34
Safety of a 3-weekly schedule of carboplatin pegylate liposomal doxorubicin as first line chemotherapy results in patients with ovarian cancer preliminary results of the MITO-2 randomized trial 32
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial 31
Carboplatin and pegylated liposomal doxorubicin for advanced ovarian cancer: preliminary activity results of the MITO-2 phase III trial. 31
High-dose Radiotherapy for Oligo-progressive NSCLC Receiving EGFR Tyrosine Kinase Inhibitors: Real World Data 30
null 29
[First line chemotherapy in non-small cell lung carcinoma: a solved dilemma] 28
null 28
A review and metanalysis of metronomic oral single-agent cyclophosphamide for treating advanced ovarian carcinoma in the era of precision medicine 27
null 27
null 26
Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice 25
5-Fluorouracil and folinic acid with or without CPT-11 in advanced colorectal cancer patients: a multicenter randomised phase II study of the Southern Italy Oncology Group 25
New Frontiers in the Treatment of Patients with HER2+ Cancer and Brain Metastases: Is Radiotherapy Always Useful? 25
Toward a New Prognostic-Therapeutic Index in Geriatric Oncology 25
Second-line Eribulin in Triple Negative Metastatic Breast Cancer patients. Multicentre Retrospective Study: The TETRIS Trial 24
Impressive objective response to nab-paclitaxel plus trastuzumab as fifth line therapy in aelderly her2-positive breast cancer patient 24
Randomised, open-label, phase II trial of paclitaxel, gemcitabine and cisplatin versus gemcitabine and cisplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium 23
Non-palpable Pulmonary Nodules and Uniportal-VATS: Radio-guided Localization (ROLL) Experience of a Lung Multidisciplinary Team 23
5-fluorouracil and levofolinic acid with or without recombinant interferon-2b in patients with advanced colorectal carcinoma: a randomized multicenter study with stratification for tumor burden and liver involvement by the Southern Italy Oncology Group 22
Gemcitabine and docetaxel every 2 weeks in advanced non-small cell lung cancer: a phase II study of the Gruppo Oncologico Italia Meridionale 22
The Effects of the Macrocyclic Lactone Bryostatin-1 on Leukemic Cells in Vitro 22
Relationship of Inflammatory Parameters and Nutritional Status in Cancer Patients 22
Combined Neuroendocrine Carcinoma and Hepatocellular Carcinoma of the Liver: Systematic Literature Review Suggests Implementing Biological Characterization to Optimize Therapeutic Strategy 22
Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study 22
Cisplatin and vinorelbine in advanced and/or metastatic adenocarcinoma of the endometrium: a new highly active chemotherapeutic regimen 22
In vivo stimulation of murine haematopoiesis by the antineoplastic agent bryostatin-1 21
First-line treatment with epirubicin and vinorelbine in metastatic breast cancer 21
Radiofrequency Thermoablation and Hypofractionated Radiotherapy Combined Treatment for Bone Metastases: A Retrospective Study 21
Liability of clinical oncologists and the COVID-19 emergency: Between hopes and concerns 21
Italian Survey on adjuvant treatment of non-small cell lung cancer (ISA) 20
Randomized phase II noncomparative trial of oral and intravenous doxifluridine plus levo-leucovorin in untreated patients with advanced colorectal carcinoma 20
Differences in the availability of new anti-cancer drugs for Italian patients treated in different regions. Results of analysis conducted by the Italian Society of Medical Oncology (AIOM) 20
A Phase I—II Study of Cyclophosphamide, Epidoxorubicin, Levofolinic Acid/5-Fluorouracil and Recombinant Human Granulocyte Colony Stimulating Factor in Metastatic Breast Carcinoma 20
TOWARD A NEW PROGNOSTIC-THERAPEUTIC INDEX IN GERIATRIC ONCOLOGY 20
Chemotherapy in Head and Neck Cancer (I): Management of Recurrent or Metastatic Disease 19
Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting. Results of a prospective randomized trial 19
Escalating doses of mitoxantrone with granulocyte colony-stimulating factor (G-CSF) rescue plus 5-fluorouracil and high-dose levofolinic acid in metastatic breast cancer 19
A combination of platinum and tamoxifen in advanced ovarian cancer failing platinum-based chemotherapy: results of a Phase II study 19
Harmful Interference of Detoxifying Diets and Nutraceuticals with Adherence to Abemaciclib in Advanced Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Breast Cancer: A Case Report 19
Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study 19
Cetuximab in squamous cell head and neck carcinomas 19
Gemcitabine plus vinorelbine in stage IIIB or IV non-small cell lung cancer (NSCLC): a multicentre phase II clinical trial 18
Treatment monitoring program for implementation of adherence to second-line erlotinib for advanced non-small-cell lung cancer 18
Does an optimal therapeutic sequence exist in advanced non-small cell lung cancer? 18
Induction pemetrexed and cisplatin followed by maintenance pemetrexed versus carboplatin plus paclitaxel plus bevacizumab followed by maintenance bevacizumab: a quality of life-oriented randomized phase III study in patients with advanced non-squamous non-small-cell lung cancer (ERACLE) 18
Virtual clinical and precision medicine tumor boards-cloud-based platform-mediated implementation of multidisciplinary reviews among oncology centers in the covid-19 era: Protocol for an observational study 18
New opioids. 18
Efficacy and safety of cetuximab/irinotecan in chemotherapy-refractory metastatic colorectal adenocarcinomas: a clinical practice setting, multicenter experience 18
Abemaciclib in Patients with End-Stage Renal Disease and Advanced Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Report of 2 Cases 18
The Consistency and Quality of ChatGPT Responses Compared to Clinical Guidelines for Ovarian Cancer: A Delphi Approach 18
Hemolytic uremic syndrome after chemotherapy with gemcitabine and taxotere: A case report 18
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study 18
null 18
Brain Metastasis in Endometrial Cancer: A Systematic Review 17
Anticancer oral therapy: Emerging related issues 17
A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trial 17
Subcutaneous recombinant-human-erythropoietin prevents chemotherapy-related anemia in patients with advanced cancer 17
MISURARE LA FRAGILITÀ DEL PAZIENTE ONCOLOGICO ANZIANO 17
Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancer 16
Nutritional management of the patient with pancreatic cancer: From the diagnostic and therapeutic pathway to an integrated hospital-territory approach 16
Irinotecan plus bolus/infusional 5-Fluorouracil and leucovorin in patients with pretreated advanced pancreatic carcinoma: a multicenter experience of the gruppo oncologico italia meridionale 16
Raltitrexed plus levofolinic acid and bolus/continuous infusion 5-fluorouracil on a biweekly schedule for elderly patients with advanced colorectal carcinomas 16
Evolution of Therapy Decision-Making Process for Advanced Non-Small Cell Lung Cancer 16
A Phase II Study of Levofolinic Acid and 5-Fluorouracil Plus Cisplatin in Patients with Advanced Head and Neck Squamous Cell Carcinoma 16
The impact of anemia on quality of life and hospitalisation in elderly cancer patients undergoing chemotherapy 16
Neo-adjuvant organ-preserving chemotherapy in the management of locally advanced oral cavity and oropharynx cancer 16
Dose intensification of mitoxantrone in combination with levofolinic acid, fluorouracil, cyclophosphamide and granulocyte colony stimulating factor support in advanced untreated breast cancer patients. A multicentric phase II study of the Southern Italy Oncology Group 16
Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management 15
Treatment of refractory metastatic breast cancer with 5-fluorouracil and levofolinic acid as 48 hours continuous venous infusion 15
Abemaciclib pharmacology and interactions in the treatment of HR+/HER2− breast cancer: a critical review 15
A pilot study of vinorelbine on a weekly schedule in recurrent and/or metastatic squamous cell carcinoma of the head and neck 15
The multipotential hematopoietic growth factors, bryostatins, inhibit human leukemia cell lines in vitro 15
Phase II study of mitomycin C, etoposide and vindesine in metastatic stage IV non-small-cell lung cancer 15
A phase I study of cisplatinum plus 5-fluorouracil in modulation with citrovorum factor in metastatic colorectal carcinoma 15
A narrative review of MET inhibitors in non-small cell lung cancer with MET exon 14 skipping mutations 15
Real-World Analysis of Adherence to Abemaciclib and Endocrine Therapy in Women with HR+/HER2− Breast Cancer 15
Disparity in the "time to patient access" to new anti-cancer drugs in Italian regions. Results of a survey conducted by the Italian Society of Medical Oncology (AIOM) 15
The Effectiveness of Combination Chemotherapy with Cisplatinum and Etoposide in the Treatment of Advanced Non-Small Cell Lung Cancer 15
5-fluorouracil plus high dose levofolinic acid and oral hydroxyurea for the treatment of primary hepatocellular carcinomas: Results of a phase II multicenter study of the Southern Italy Oncology Group (G.O.I.M.) 15
Totale 2.785
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.708
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.708
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202226 0 0 0 0 0 0 0 5 2 7 2 10
2022/2023174 13 14 4 8 6 13 3 12 8 3 49 41
2023/2024970 39 84 66 77 138 104 158 62 50 52 40 100
2024/20253.940 423 366 528 100 512 470 409 278 757 97 0 0
Totale 5.110